Kamran Alam
About Kamran Alam
Kamran Alam Executive Vice President and CFO
Kamran Alam serves as the Executive Vice President, Finance and Chief Financial Officer. In these roles, he oversees the financial operations and strategy of the organization, ensuring fiscal responsibility and guiding financial decisions.
Interim Chief Financial Officer at Neoleukin Therapeutics
Kamran Alam took on the role of Interim Chief Financial Officer at Neoleukin Therapeutics, Inc. following its 2019 merger with Aquinox Pharmaceuticals, Inc. He led the financial integration and operations during this transitional period.
Finance Leadership at Aquinox Pharmaceuticals IPO
Kamran Alam provided crucial finance leadership for Aquinox Pharmaceuticals during its Initial Public Offering (IPO) on the NASDAQ stock exchange in 2014. His expertise in financial management was pivotal to the company's successful entry into the public market.
Senior Roles in Biotechnology and Pharmaceutical Business Development
Kamran Alam has held multiple senior roles in business development across various biotechnology and pharmaceutical companies. His responsibilities included driving strategic growth initiatives and overseeing business operations in these sectors.
Kamran Alam's Educational Background
Kamran Alam holds a B.Sc. in Cell Biology and Genetics from the University of British Columbia. He also earned an M.B.A. in International Business and Strategy from the University of Victoria. These academic credentials provide a strong foundation for his career in finance and business development.
Kamran Alam Chartered Professional Accountant
Kamran Alam is a Chartered Professional Accountant, a designation that signifies a high level of expertise and professionalism in accounting. This qualification underlines his capabilities in financial management and strategic planning.